openPR Logo
Press release

Male Infertility Market is Expected to Reach $301.5 Million, Globally, by 2020

10-10-2018 07:25 PM CET | Health & Medicine

Press release from: Allied Market Research

Male Infertility Market is Expected to Reach $301.5 Million,

Male Infertility Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $301.5 million by 2020, registering a CAGR of 5% during the period 2014-2020.

"Geographically, male infertility is segmented in to North America, Europe, Asia Pacific and RoW. The geographic market would be dominated by the North American region by 2020. This is due to the increased adoption of newer techniques such as DNA fragmentation in the routine analysis test for male infertility. The Asia Pacific and RoW region are expected to have the highest CAGR during the analysis period. This is due to the increase in male infertility awareness and rising awareness about the treatments that are available."

Request sample copy of this report @ https://www.alliedmarketresearch.com/request-sample/241

Infertility in male is characterized by various infertility related problems such as low sperm count, presence of low motile sperm or azoospermia. The various causes of male infertility include stress, consumption of alcohol or drugs, smoking, obesity, environmental toxins, etc. These factors also act as driving factors of the male infertility market. When an individual is diagnosed with infertility, the person undergoes immense stress, embarrassment and guilt, which would further intensify the infertility problem. This is a major limitation of this market. The opportunity for the growth of this market is the increase in awareness levels among men and rising trend in medical tourism.

The male infertility market is segmented based on techniques, namely DNA fragmentation, oxidative stress analysis, sperm agglutination test, sperm penetration test, microscopic examination, computer assisted semen analysis and others. The DNA fragmentation would be the highest revenue generating market by 2020 and is also expected to have the highest CAGR during the analysis period, when compared to the other segments in the techniques market. This is due to the accuracy level the test provides in identifying the level of infertility by measuring the level of DNA damage.

The key companies profiled in the report are ASKA Pharmaceutical Co. Ltd, ZydusCadila Healthcare Limited, Access Pharmaceuticals, Inc., Intas Pharmaceuticals Ltd., Pantarhei Bioscience B, Cordex Pharma, Inc., Merck Serono, Halotech DNA SL, SCSA diagnostics, Andrology Solutions.

Male Infertility Market Segments covered in the report:

By Techniques
• DNA Fragmentation Technique
• Oxidative Stress Analysis
• Microscopic Examination
• Sperm Penetration Assay
• Sperm Agglutination
• Computer Assisted Semen Analysis
• Others

By Geography
• North America
• Europe
• Asia Pacific
• RoW

Check offers and discount on this report @ https://www.alliedmarketresearch.com/get-discount/241

About Us:

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Male Infertility Market is Expected to Reach $301.5 Million, Globally, by 2020 here

News-ID: 1294869 • Views:

More Releases from Allied Market Research

Hotel Toiletries Market Revenue is expected to Surpass $50.5 billion by 2031
Hotel Toiletries Market Revenue is expected to Surpass $50.5 billion by 2031
The hotel toiletries market was valued at $17.9 billion in 2021, and is estimated to reach $50.5 billion by 2031, growing at a CAGR of 10.8% from 2022 to 2031. Get Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/75060 There is a greater demand for hotel toiletries with the growth of the tourism industry and the rise in international travel. Improved transportation, economic growth, globalization, technology advancements, and other initiatives have
False Lashes Market to Grow at a CAGR of 6.5% and will Reach USD 2.4 billion by 2031
False Lashes Market to Grow at a CAGR of 6.5% and will Reach USD 2.4 billion by …
According to a new report published by Allied Market Research, titled, "False Lashes Market," The false lashes market size was valued at $1.3 billion in 2021, and is estimated to reach $2.4 billion by 2031, growing at a CAGR of 6.5% from 2022 to 2031. Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/6826 False lashes are for people with short or thin eyelashes. They consist of synthetic or human
Tourism Source Market Size Worth USD 1.1 Trillion by 2032 | Growth Rate (CAGR) of 6.6%
Tourism Source Market Size Worth USD 1.1 Trillion by 2032 | Growth Rate (CAGR) o …
The Tourism Source Market Size was valued at $599.40 billion in 2022, and is estimated to reach $1.1 Trillion by 2032, growing at a CAGR of 6.6% from 2023 to 2032. Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/6807 Traveling to other locations for pleasure, recreation, or business is referred to as tourism. It entails travelling to and taking in a variety of locations, points of interest, and cultural
Music Event Market is poised to reach USD 775.7 billion, growing at a 10.2% CAGR by 2035
Music Event Market is poised to reach USD 775.7 billion, growing at a 10.2% CAGR …
The music event market size was valued at $250.80 billion in 2023, and is estimated to reach $775.7 billion by 2035, growing at a CAGR of 10.2% from 2024 to 2035. Get Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/A08029 Music events are live or virtual gatherings where performers showcase their musical talent to audiences, serving as a pillar of the entertainment industry. These events have various formats,

All 5 Releases


More Releases for Infertility

Shaping the Female Infertility Market in 2025: Rising Infertility Trends Driving …
How Big Is the Female Infertility Market Expected to Be, and What Will Its Growth Rate Be? In recent times, there has been a regular expansion in the market size of female infertility. The market is predicted to increase from $1.79 billion in 2024 to $1.87 billion in 2025, experiencing a compound annual growth rate (CAGR) of 4.5%. The reasons behind the growth during the historic period include the rising trend
Infertility Treatment Market - Unveiling the Path to Fulfillment: Transforming L …
Newark, New Castle, USA - new report, titled Infertility Treatment Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Infertility Treatment market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Infertility Treatment market. The report offers an overview of the market, which
Male Infertility Market Size Analysis, Industry Outlook, Regional Forecast 2021- …
Idiopathic infertility and varicocele infertility are the two most common types of male infertility. Surgery, treatment for intercourse issues, hormone treatment, and ART technologies are the most common therapies for male infertility. The global rate of infertility is steadily rising in both developed and developing countries. The global Male Infertility market size is projected to reach US$ 3773.8 million by 2027, from US$ 2738.4 million in 2020, at a CAGR
Infertility Drugs Market Increasing Research & Development for More Effective Tr …
Infertility is a global health issue as its affects both men and women. Infertility in females occur due to increasing age, polycystic ovarian syndrome (PCOS), obesity, and multiple miscarriages whereas in males infertility occur due to erectile dysfunction, low sperm count, abnormal sperms, etc. Increasing prevalence of infertility is expected to propel demand for the infertility drugs. According to World Health Organization (WHO) 2012 report, infertility affects one out of
Global Infertility Drug Pipeline Analysis
The market for reproductive medicine is experiencing a paradigm shift with new latest techniques being used and awareness among people increasing due to imparting knowledge about these techniques. The infertility drugs market promises significant room for growth. The market has high potential to scale up in order to meet the needs of infertile couples and also due to growth in reproductive tourism. Venture capitalists have entered the market by investing
Female Infertility-Pipeline Insights, 2017
This report helps to analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Female Infertility-Pipeline Insights, 2017 “Female Infertility-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Female Infertility. The Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III